Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec 21:8:180.
doi: 10.1186/1742-2094-8-180.

The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism

Affiliations

The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism

Gehan A Mostafa et al. J Neuroinflammation. .

Abstract

Background: Neurogenic inflammation is orchestrated by a large number of neuropeptides. Tachykinins (substance P, neurokinin A and neurokinin B) are pro-inflammatory neuropeptides that may play an important role in some autoimmune neuroinflammatory diseases. Autoimmunity may have a role in the pathogenesis of autism in some patients. We are the first to measure serum neurokinin A levels in autistic children. The relationship between serum levels of neurokinin A and anti-ribosomal P protein antibodies was also studied.

Methods: Serum neurokinin A and anti-ribosomal P protein antibodies were measured in 70 autistic children in comparison to 48 healthy-matched children.

Results: Autistic children had significantly higher serum neurokinin A levels than healthy controls (P < 0.001). Children with severe autism had significantly higher serum neurokinin A levels than patients with mild to moderate autism (P < 0.001). Increased serum levels of neurokinin A and anti-ribosomal P protein antibodies were found in 57.1% and 44.3%, respectively of autistic children. There was significant positive correlations between serum levels of neurokinin A and anti-ribosomal P protein antibodies (P = 0.004).

Conclusions: Serum neurokinin A levels were elevated in some autistic children and they were significantly correlated to the severity of autism and to serum levels of anti-ribosomal P protein antibodies. However, this is an initial report that warrants further research to determine the pathogenic role of neurokinin A and its possible link to autoimmunity in autism. The therapeutic role of tachykinin receptor antagonists, a potential new class of anti-inflammatory medications, should also be studied in autism.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Positive correlations between serum levels of neurokinin A and CARS in children with autism. CARS: Childhood Autism Rating Scale.
Figure 2
Figure 2
Positive correlations between serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism.

Similar articles

Cited by

References

    1. Geppetti P, Nassini R, Materazzi S, Benemei S. The concept of neurogenic inflammation. BJU Int. 2008;101(Suppl 3):2–6. - PubMed
    1. Richardson JD, Vasko MR. Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther. 2002;302(3):839–45. doi: 10.1124/jpet.102.032797. - DOI - PubMed
    1. Nockher WA, Renz H. Neurotrophins in inflammatory lung diseases: modulators of cell differentiation and neuroimmune interactions. Cytokine Growth Factor Rev. 2003;14:559–78. doi: 10.1016/S1359-6101(03)00071-6. - DOI - PubMed
    1. Micera A, Lambiase A, Bonini S. The role of neuromediators neuromediators in ocular allergy. Curr Opin Allergy Clin Immunol. 2008;8(5):466–71. doi: 10.1097/ACI.0b013e32830e6b17. - DOI - PubMed
    1. Maggi CA. The troubled story of tachykinins and neurokinins. Trends Pharmacol Sci. 2000;21:173–175. doi: 10.1016/S0165-6147(00)01463-2. - DOI - PubMed

Publication types

LinkOut - more resources